Clinical Trial Update: Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

View source ↗

Summary

This completed DECIDER trial evaluated patient preferences for prostate cancer treatment attributes using a survey-based discrete choice experiment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer | Status: COMPLETED